Redeye: BIMobject - Turning Focus to New Sales and Expansion

Redeye lowers its forecasts and Base Case following a Q4 report with softer ARR growth than expected. However, the almost complete migration to the new plans paves the way for increased ARR growth in 2022.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.

Source: MFN

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.